Accelerate IVD Innovation with End-to-End CDMO R&D Expertise
In Vitro Diagnostics (IVD) demands robust, reproducible analytical workflows to deliver consistent, clinically compliant diagnostic performance. Our full-service CDMO R&D division covers the complete IVD development lifecycle: from target biomaterial screening, antigen/antibody custom development, assay formula construction, analytical performance optimization, interference & stability validation, up to pre-production process transfer for commercial manufacturing.
Combining GMP-aligned laboratory infrastructure, ISO13485 compliant quality management system and cross-disciplinary IVD scientist team, we streamline your R&D cycle, cut upfront lab investment and minimize technical & regulatory risks across all mainstream IVD technical platforms:
Immunodiagnostic Platforms: CLIA Chemiluminescence, ELISA Enzyme Immunoassay, Fluorescence Immunoassay(FIA), Latex Turbidimetry, Lateral Flow POCT Rapid Test
Molecular Diagnostic Platforms: Real-Time qPCR, Isothermal Amplification, Multiplex Nucleic Acid Detection, Extraction Kit Formulation, Companion Diagnostic Assay Development
Specialized Custom Projects: Calibrator & Quality Control Material R&D, Matrix-based Reference Panel Preparation, In-house Substrate & Biochemical Reagent Custom Synthesis
Our experienced R&D scientists conduct formulation screening, precision performance testing and accelerated stability validation under ISO13485 controlled cleanroom laboratory environments.